Skip to main content Accessibility help
×
Home
Hostname: page-component-55597f9d44-54vk6 Total loading time: 0.329 Render date: 2022-08-19T02:29:40.267Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true } hasContentIssue true

Neuroendocrine Responses As an Indicator of Recurrence Liability in Primary Affective Illness

Published online by Cambridge University Press:  29 January 2018

Eva Grof
Affiliation:
Departments of Psychiatry and Neurosciences, McMaster University, Hamilton, Ontario
Gregory M. Brown
Affiliation:
Departments of Psychiatry and Neurosciences, McMaster University, Hamilton, Ontario
Paul Grof
Affiliation:
Departments of Psychiatry and Neurosciences, McMaster University, Hamilton, Ontario
Rights & Permissions[Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1982 

References

1 Carroll, B. J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A., Haskett, R., James, N., Kronfol, Z., Lohr, N., Steiner, M., DeVigne, J. P. & Young, E. (1981) A specific laboratory test for the diagnosis of melancholia. Archives of General Psychiatry, 38, 1522.CrossRefGoogle Scholar
2 Albala, A. A., Greden, J. F., Tarika, J. & Carroll, B. J. (1981) Changes in serial dexamethasone suppression tests among unipolar depressives receiving electroconvulsive treatment. Biological Psychiatry, in press.Google Scholar
3 de la Fuente, J. & Rosenbaum, A. H. (1980) Neuroendocrine dysfunction and blood levels of tricyclic antidepressants. American Journal of Psychiatry, 137, 1260–1.Google ScholarPubMed
4 Goldberg, I. K. (1980) Dexamethasone suppression test as an indicator of safe withdrawal of antidepressant therapy. Lancet, i, 376.CrossRefGoogle Scholar
5 Goldberg, I. K. (1980) Dexamethasone suppression tests in depression and response to treatment. Lancet, ii, 92.CrossRefGoogle Scholar
6 Greden, J. F., DeVigne, J. P., Albala, A. A., Tarika, J., Buttenhiem, M., Eiser, A. & Carroll, B. J. (1981) Post-dexamethasone plasma Cortisol levels among lithium treated rapidly cycling bipolar patients. In The Prediction of Lithium Response (ed. Dufour, H.). Paris: Economica, in press.Google Scholar
7 Kirkegaard, C., Norlem, N., Lauridsen, U. B. & Bjoerum, N. (1980) Prognostic value of thyrotropin-releasing hormone stimulation test in endogenous depression. Acta Psychiatrica Scandinavica, 52, 170–7.Google ScholarPubMed
8 Kirkegaard, C. & Bjoerum, N. (1980) TSH responses to TRH in endogenous depression. Lancet, i, 152.CrossRefGoogle Scholar
9 Langer, G., Schonbeck, G., Koinig, G., Schussler, M. & Reiter, H. (1980) Neuroendocrine status of depressed patients at admission and during antidepressant drug treatment (Clomipramine). Neuropsychobiology, 6, 153.Google Scholar
10 Langer, G., Schonbeck, G., Koinig, G. & Aschauer, H. (1981) Neuroendocrine mechanisms in therapeutic effects of antidepressant drugs: The “Thyroid axis” hypothesis. Presentation—3rd World Congress Biological Psychiatry, Stockholm. Abstracts S-211.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.
You have Access
5
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Neuroendocrine Responses As an Indicator of Recurrence Liability in Primary Affective Illness
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Neuroendocrine Responses As an Indicator of Recurrence Liability in Primary Affective Illness
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Neuroendocrine Responses As an Indicator of Recurrence Liability in Primary Affective Illness
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *